Table 1. Basic characteristics of the selected countries.
| Characteristic | Australia | Japan | Israel | United Kingdom | United States | South Korea | Singapore | India |
|---|---|---|---|---|---|---|---|---|
| Population in millions | 25.5 | 126.5 | 8.65 | 67.9 | 331.0 | 51.27 | 5.85 | 1380.0 |
| Population density per km2 | 3.202 | 347.778 | 402.606 | 272.898 | 35.608 | 527.967 | 7915.731 | 450.419 |
| Age 70 years or older (%) | 10.129 | 18.493 | 7.359 | 12.527 | 9.732 | 8.622 | 7.049 | 3.414 |
| GDP per person (USD) | 44,648.71 | 39,002.22 | 33,132.32 | 39,753.24 | 54,225.45 | 35,938.37 | 85,535.38 | 6,426.674 |
| Extreme poverty (%) | 0.5 | - | 0.5 | 0.2 | 1.2 | 0.2 | - | 21.2 |
| Hospital beds per thousand | 3.84 | 13.05 | 2.99 | 2.54 | 2.77 | 12.27 | 2.4 | 0.53 |
| Life expectancy (years) | 83.44 | 84.63 | 82.97 | 81.32 | 78.86 | 83.03 | 83.62 | 69.66 |
| Human development index | 0.944 | 0.919 | 0.919 | 0.922 | 0.926 | 0.916 | 0.938 | 0.645 |
| GHS | 75.5 | 59.8 | 47.3 | 77.9 | 83.5 | 70.2 | 58.7 | 46.5 |
| Start date of vaccination (dd/mm/yy) | 22/2/21 | 17/2/21 | 19/12/20 | 3/1/21 | 20/12/20 | 25/2/21 | 11/1/21 | 15/1/21 |
| Vaccine coverage (%)* | 27.80 | 46.42 | 62.45 | 62.91 | 51.77 | 30.70 | 75.21 | 10.61 |
| Initial vaccine | Pfizer/AstraZeneca | Pfizer | Pfizer | Pfizer | Pfizer | Pfizer/AstraZeneca | Pfizer/Sinovac | AstraZeneca/Covaxin |
GDP, Gross Domestic Product; GHS, Global health security; *2021/08/31